001     136848
005     20240229105103.0
024 7 _ |a 10.2196/10976
|2 doi
024 7 _ |a pmid:30111525
|2 pmid
024 7 _ |a 1438-8871
|2 ISSN
024 7 _ |a 1439-4456
|2 ISSN
024 7 _ |a altmetric:46548370
|2 altmetric
037 _ _ |a DKFZ-2018-01286
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Brinker, Titus Josef
|0 0000-0002-3620-5919
|b 0
|e First author
245 _ _ |a A Face-Aging App for Smoking Cessation in a Waiting Room Setting: Pilot Study in an HIV Outpatient Clinic.
260 _ _ |a Richmond, Va.
|c 2018
|b Healthcare World
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1552642935_30636
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a There is strong evidence for the effectiveness of addressing tobacco use in health care settings. However, few smokers receive cessation advice when visiting a hospital. Implementing smoking cessation technology in outpatient waiting rooms could be an effective strategy for change, with the potential to expose almost all patients visiting a health care provider without preluding physician action needed.The objective of this study was to develop an intervention for smoking cessation that would make use of the time patients spend in a waiting room by passively exposing them to a face-aging, public morphing, tablet-based app, to pilot the intervention in a waiting room of an HIV outpatient clinic, and to measure the perceptions of this intervention among smoking and nonsmoking HIV patients.We developed a kiosk version of our 3-dimensional face-aging app Smokerface, which shows the user how their face would look with or without cigarette smoking 1 to 15 years in the future. We placed a tablet with the app running on a table in the middle of the waiting room of our HIV outpatient clinic, connected to a large monitor attached to the opposite wall. A researcher noted all the patients who were using the waiting room. If a patient did not initiate app use within 30 seconds of waiting time, the researcher encouraged him or her to do so. Those using the app were asked to complete a questionnaire.During a 19-day period, 464 patients visited the waiting room, of whom 187 (40.3%) tried the app and 179 (38.6%) completed the questionnaire. Of those who completed the questionnaire, 139 of 176 (79.0%) were men and 84 of 179 (46.9%) were smokers. Of the smokers, 55 of 81 (68%) said the intervention motivated them to quit (men: 45, 68%; women: 10, 67%); 41 (51%) said that it motivated them to discuss quitting with their doctor (men: 32, 49%; women: 9, 60%); and 72 (91%) perceived the intervention as fun (men: 57, 90%; women: 15, 94%). Of the nonsmokers, 92 (98%) said that it motivated them never to take up smoking (men: 72, 99%; women: 20, 95%). Among all patients, 102 (22.0%) watched another patient try the app without trying it themselves; thus, a total of 289 (62.3%) of the 464 patients were exposed to the intervention (average waiting time 21 minutes).A face-aging app implemented in a waiting room provides a novel opportunity to motivate patients visiting a health care provider to quit smoking, to address quitting at their subsequent appointment and thereby encourage physician-delivered smoking cessation, or not to take up smoking.
536 _ _ |a 317 - Translational cancer research (POF3-317)
|0 G:(DE-HGF)POF3-317
|c POF3-317
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Brieske, Christian Martin
|0 0000-0002-8528-6022
|b 1
700 1 _ |a Esser, Stefan
|0 0000-0002-3625-9650
|b 2
700 1 _ |a Klode, Joachim
|0 0000-0001-9239-7014
|b 3
700 1 _ |a Mons, Ute
|0 P:(DE-He78)1b59582b6c05ac4e57aa8b90dd9667f9
|b 4
|u dkfz
700 1 _ |a Batra, Anil
|0 0000-0001-7470-9037
|b 5
700 1 _ |a Rüther, Tobias
|0 0000-0002-3717-6339
|b 6
700 1 _ |a Seeger, Werner
|0 0000-0003-1946-0894
|b 7
700 1 _ |a Enk, Alexander H
|0 0000-0002-7358-185X
|b 8
700 1 _ |a von Kalle, Christof
|0 P:(DE-He78)5bacb661d5d7c0220d8f996d980ad8de
|b 9
|u dkfz
700 1 _ |a Berking, Carola
|0 0000-0003-0229-8931
|b 10
700 1 _ |a Heppt, Markus V
|0 0000-0003-4603-1825
|b 11
700 1 _ |a Gatzka, Martina V
|0 0000-0001-6520-9794
|b 12
700 1 _ |a Bernardes-Souza, Breno
|0 0000-0003-1806-2501
|b 13
700 1 _ |a Schlenk, Richard
|0 P:(DE-He78)d8a0e60e5e095f3161ee0de3712409bc
|b 14
|u dkfz
700 1 _ |a Schadendorf, Dirk
|0 0000-0003-3524-7858
|b 15
773 _ _ |a 10.2196/10976
|g Vol. 20, no. 8, p. e10976 -
|0 PERI:(DE-600)2028830-X
|n 8
|p e10976
|t Journal of medical internet research
|v 20
|y 2018
|x 1438-8871
909 C O |p VDB
|o oai:inrepo02.dkfz.de:136848
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 0000-0002-3620-5919
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)1b59582b6c05ac4e57aa8b90dd9667f9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)5bacb661d5d7c0220d8f996d980ad8de
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)d8a0e60e5e095f3161ee0de3712409bc
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-317
|2 G:(DE-HGF)POF3-300
|v Translational cancer research
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2018
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J MED INTERNET RES : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)G100-20160331
|k G100
|l Translationale Onkologie
|x 0
920 1 _ |0 I:(DE-He78)M050-20160331
|k M050
|l Krebsprävention
|x 1
920 1 _ |0 I:(DE-He78)G040-20160331
|k G040
|l Klinische Studienzentrale
|x 2
920 1 _ |0 I:(DE-He78)L101-20160331
|k L101
|l DKTK Heidelberg
|x 3
920 1 _ |0 I:(DE-He78)L401-20160331
|k L401
|l DKTK Essen
|x 4
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)G100-20160331
980 _ _ |a I:(DE-He78)M050-20160331
980 _ _ |a I:(DE-He78)G040-20160331
980 _ _ |a I:(DE-He78)L101-20160331
980 _ _ |a I:(DE-He78)L401-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21